Physician profile

Eliza E Robertson

Neurology (Psychiatry & Neurology) · Lexington, KY

NPI 1184771982

$721.98

in general payments reported to CMS, 2019-2025

11 companies · none reported in 2025

See the full distribution for Neurology (Psychiatry & Neurology)

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$18.80

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Amgen INC. $203.54 2019-2021
Acadia Pharmaceuticals INC $112.14 2020
Allergan, INC. $110.46 2019-2021
Csl Behring $88.16 2019
Biogen, INC. $68.10 2019-2020
Novartis Pharmaceuticals Corporation $46.14 2019-2020
Kyowa Kirin, INC. $21.23 2019
Acorda Therapeutics, INC $20.03 2019
Abbvie INC. $18.80 2024
Aprecia Pharmaceuticals, LLC $16.69 2020
Lilly USA, LLC $16.69 2020

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Eliza E Robertson

$721.98

in general payments reported 2019-2025

Years
2019-2024
Top company
Amgen INC.

https://glasscript.com/doctor/235670/eliza-e-robertson

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.